These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 1656855)
1. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Raimondi A; Traverso A; Nikaido H Antimicrob Agents Chemother; 1991 Jun; 35(6):1174-80. PubMed ID: 1656855 [TBL] [Abstract][Full Text] [Related]
2. Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Cornaglia G; Russell K; Satta G; Fontana R Antimicrob Agents Chemother; 1995 Feb; 39(2):350-5. PubMed ID: 7726496 [TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen HY; Livermore DM J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068 [TBL] [Abstract][Full Text] [Related]
4. In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem. Pragai Z; Nagy E J Antimicrob Chemother; 1998 Dec; 42(6):821-4. PubMed ID: 10052909 [TBL] [Abstract][Full Text] [Related]
5. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Lee EH; Nicolas MH; Kitzis MD; Pialoux G; Collatz E; Gutmann L Antimicrob Agents Chemother; 1991 Jun; 35(6):1093-8. PubMed ID: 1929248 [TBL] [Abstract][Full Text] [Related]
6. Diffusion of carbapenems through the outer membrane of enterobacteriaceae and correlation of their activities with their periplasmic concentrations. Cornaglia G; Mazzariol A; Fontana R; Satta G Microb Drug Resist; 1996; 2(2):273-6. PubMed ID: 9158772 [TBL] [Abstract][Full Text] [Related]
7. Why are carbapenems active against Enterobacter cloacae resistant to third generation cephalosporins? Pechère JC Scand J Infect Dis Suppl; 1991; 78():17-21. PubMed ID: 1658922 [TBL] [Abstract][Full Text] [Related]
8. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Livermore DM Antimicrob Agents Chemother; 1992 Sep; 36(9):2046-8. PubMed ID: 1329641 [TBL] [Abstract][Full Text] [Related]
9. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Cornaglia G; Guan L; Fontana R; Satta G Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880 [TBL] [Abstract][Full Text] [Related]
10. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms. Livermore DM; Yang YJ J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657 [TBL] [Abstract][Full Text] [Related]
11. Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae. Lee EH; Collatz E; Trias J; Gutmann L J Gen Microbiol; 1992 Nov; 138(11):2347-51. PubMed ID: 1336033 [TBL] [Abstract][Full Text] [Related]
12. Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae. Mimoz O; Leotard S; Jacolot A; Padoin C; Louchahi K; Petitjean O; Nordmann P Antimicrob Agents Chemother; 2000 Apr; 44(4):885-90. PubMed ID: 10722486 [TBL] [Abstract][Full Text] [Related]
13. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Mainardi JL; Mugnier P; Coutrot A; Buu-Hoï A; Collatz E; Gutmann L Antimicrob Agents Chemother; 1997 Nov; 41(11):2352-4. PubMed ID: 9371332 [TBL] [Abstract][Full Text] [Related]
15. Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2. Fung-Tomc JC; Gradelski E; Kolek B; Minassian B; Pucci M; Kessler RE; Bonner DP Antimicrob Agents Chemother; 1995 Feb; 39(2):386-93. PubMed ID: 7726503 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J J Clin Microbiol; 2000 Sep; 38(9):3299-305. PubMed ID: 10970374 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases. Livermore DM; Chen HY J Antimicrob Chemother; 1997 Sep; 40(3):335-43. PubMed ID: 9338484 [TBL] [Abstract][Full Text] [Related]
18. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases]. Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065 [TBL] [Abstract][Full Text] [Related]
19. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762 [TBL] [Abstract][Full Text] [Related]
20. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]